Foyston, Gordon, & Payne’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-40,713
Closed -$7.91M 57
2022
Q4
$7.91M Sell
40,713
-8,478
-17% -$1.55M 2.19% 15
2022
Q3
$8.43M Buy
49,191
+6,413
+15% +$1.26M 2.31% 16
2022
Q2
$9.98M Sell
42,778
-2,257
-5% -$452K 2.89% 9
2022
Q1
$10.7M Buy
45,035
+7,684
+21% +$1.81M 2.62% 14
2021
Q4
$10.9M Buy
37,351
+4,365
+13% +$1.22M 2.55% 13
2021
Q3
$8.36M Sell
32,986
-2,204
-6% -$573K 2.09% 17
2021
Q2
$8.43M Sell
35,190
-9,584
-21% -$2.14M 2% 19
2021
Q1
$8.11M Buy
44,774
+22,170
+98% +$3.92M 1.91% 17
2020
Q4
$4.36M Buy
+22,604
New +$3.8M 1.05% 35

Other funds holding EFX

Foyston, Gordon, & Payne's EFX Position: Q1 2023 in Review

Foyston, Gordon, & Payne sold out of Equifax (EFX) in Q1 2023, closing a stake of 40,713 shares — an estimated $7.91M sold.

Foyston, Gordon, & Payne first reported a position in EFX in Q4 2020 and held it in 9 quarters. The position peaked at $10.9M in Q4 2021. 664 funds tracked by Wall St. Rank hold EFX as of Q1 2023.

  • Foyston, Gordon, & Payne reported no remaining Equifax position as of Q1 2023 after selling out during the quarter.
  • Foyston, Gordon, & Payne sold 40,713 Equifax shares in Q1 2023, an estimated $7.91M.
  • Foyston, Gordon, & Payne first reported a position in Equifax in Q4 2020 and held it in 9 quarters.
  • Foyston, Gordon, & Payne's Equifax position peaked at $10.9M in Q4 2021.
  • 664 funds tracked by Wall St. Rank held Equifax as of Q1 2023.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2023, filed 3 May 2023.